RGT
Click for more information
0.00% 29.0¢ argent biopharma limited

Disappointed, page-40

  1. Kazzmatt1
    255 Posts.
    clock Created with Sketch.
    25/01/18
    17:48
    Post #: 30577660
    Alot of people whinging about this company but honestly what did they expect, a little surge and a mild retrace tbh on good news I was surprised that we didnt drop below 10c today historically thats been the way. seems like people are buying this company with the hopes of hitting it big, hope they enjoy losing their money when they sell out in disappointment, as for me I am all to happy to sit here for the next couple of years.
    MXC Price at posting: 11.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RZI https://hotcopper.com.au/news/asx-news/149063/fast-track-assaying-yields-182-g-t-gold-for-itech-at-new-nt-play/
right-arrow Created with Sketch.
ALK Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26
right-arrow Created with Sketch.
NEWS The Big Deal: Free-to-air TV swings the axe, but will it be enough as enormous sports deal bills loom?
right-arrow Created with Sketch.
CUV British study shows Clinuvel drug effective on DNA of UV-damaged skin
right-arrow Created with Sketch.
AWJ Auric jumps 10% on maiden cash sales in Q3CY24 and firm guidance
right-arrow Created with Sketch.
ITM Fast-track assaying yields 182 g/t gold for iTech at new NT play
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
29.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $13.31M
Open High Low Value Volume
29.0¢ 29.0¢ 29.0¢ $22 75

Buyers (Bids)

No. Vol. Price($)
5 6566 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 44617 1
View Market Depth
Last trade - 12.25pm 05/07/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.